#cellfreedna search results

#CellFreeDNA detects Hodgkin/R-S genomic imbalances in early & advanced disease. MRD next? ncbi.nlm.nih.gov/pubmed/26687610

evemariecrane's tweet image. #CellFreeDNA detects Hodgkin/R-S genomic imbalances in early & advanced disease. MRD next? ncbi.nlm.nih.gov/pubmed/26687610
evemariecrane's tweet image. #CellFreeDNA detects Hodgkin/R-S genomic imbalances in early & advanced disease. MRD next? ncbi.nlm.nih.gov/pubmed/26687610

Tx immunologists are essential to improving services. Much more than tissue typing including access to Tx for highly sensitised patients previously deemed untransplantable. They aren’t standing still-research & tech constantly evolving #iSqueek #cellfreeDNA #NWTransplantMeeting

SmeetaSinha's tweet image. Tx immunologists are essential to improving services. Much more than tissue typing including access to Tx for highly sensitised patients previously deemed untransplantable. They aren’t standing still-research & tech constantly evolving #iSqueek #cellfreeDNA #NWTransplantMeeting
SmeetaSinha's tweet image. Tx immunologists are essential to improving services. Much more than tissue typing including access to Tx for highly sensitised patients previously deemed untransplantable. They aren’t standing still-research & tech constantly evolving #iSqueek #cellfreeDNA #NWTransplantMeeting
SmeetaSinha's tweet image. Tx immunologists are essential to improving services. Much more than tissue typing including access to Tx for highly sensitised patients previously deemed untransplantable. They aren’t standing still-research & tech constantly evolving #iSqueek #cellfreeDNA #NWTransplantMeeting

Great talk by Max Diehl at @AACR #liquidbiopsies about how #cellfreeDNA assays can facilitate new clinical paradigms in part because they can be done repeatedly as opposed to other measurements.

AuclairDan's tweet image. Great talk by Max Diehl at @AACR #liquidbiopsies about how #cellfreeDNA assays can facilitate new clinical paradigms in part because they can be done repeatedly as opposed to other measurements.
AuclairDan's tweet image. Great talk by Max Diehl at @AACR #liquidbiopsies about how #cellfreeDNA assays can facilitate new clinical paradigms in part because they can be done repeatedly as opposed to other measurements.
AuclairDan's tweet image. Great talk by Max Diehl at @AACR #liquidbiopsies about how #cellfreeDNA assays can facilitate new clinical paradigms in part because they can be done repeatedly as opposed to other measurements.
AuclairDan's tweet image. Great talk by Max Diehl at @AACR #liquidbiopsies about how #cellfreeDNA assays can facilitate new clinical paradigms in part because they can be done repeatedly as opposed to other measurements.

The people who make #ICGEBCapeTown Dada Oluwaseyi Temilola #ICGEB Arturo Falaschi PhD Fellow 'My research is focused on the role of #cellfreeDNA in the diagnosis and prognosis of #prostatecancer in the #SouthAfrican population'

ICGEBCapeTown's tweet image. The people who make #ICGEBCapeTown

Dada Oluwaseyi Temilola #ICGEB Arturo Falaschi PhD Fellow

'My research is focused on the role of #cellfreeDNA in the diagnosis and prognosis of #prostatecancer in the #SouthAfrican population'

.@chattertonzac et al. From @Sydney_Uni detected neural trauma in @USNavy personnel subjected to explosive blasts using a #cellfreeDNA methylation assay. Also used to detect neurodegeneration. Preprint here: biorxiv.org/content/10.110…

martinalexsmith's tweet image. .@chattertonzac et al. From @Sydney_Uni detected neural trauma in @USNavy personnel subjected to explosive blasts using a #cellfreeDNA methylation assay. 

Also used to detect neurodegeneration. Preprint here:
biorxiv.org/content/10.110…
martinalexsmith's tweet image. .@chattertonzac et al. From @Sydney_Uni detected neural trauma in @USNavy personnel subjected to explosive blasts using a #cellfreeDNA methylation assay. 

Also used to detect neurodegeneration. Preprint here:
biorxiv.org/content/10.110…

Exciting presentation by @DrSarahSheppard at @ISSVA1992 virtual meeting on the use of #CellFreeDNA to diagnose #VascularAnomalies. Lets all work together to move this research forward!

NucleatedRBC's tweet image. Exciting presentation by @DrSarahSheppard at @ISSVA1992 virtual meeting on the use of #CellFreeDNA to diagnose #VascularAnomalies.  Lets all work together to move this research forward!

Liquid Biopsy Surge Is Reaching Beyond Cancer to Infectious Disease @QmedNews #cellfreeDNA #microbes #kariustest ow.ly/Yng730ejGt6

KariusInc's tweet image. Liquid Biopsy Surge Is Reaching Beyond Cancer to Infectious Disease @QmedNews #cellfreeDNA #microbes #kariustest ow.ly/Yng730ejGt6

UW Study Demonstrates Tracking of #CellFreeDNA to Origin in Body - go.shr.lc/1NbXrQi @uwgenome

ExosomeRNA's tweet image. UW Study Demonstrates Tracking of #CellFreeDNA to Origin in Body - go.shr.lc/1NbXrQi @uwgenome

Would be thrilled if #cellfreeDNA were available to our #HTx pts in Canada - a dream come true to avoid surveillance biopsies ⁦@ShelleyZieroth⁩ ⁦@3rdheartsound⁩ ⁦@PalakShahMD⁩ ⁦@RyanDaveyMD⁩ ⁦@KiranDSidhu⁩ ⁦@OKiamaneshuhn.ca/corporate/News…


cfDNA was detectable in 249 patients (96,9%) and correlated with LDH and Ann Arbor stage. #cellfreeDNA, #ASH2019, #HematologyHospitaldelMar,#lymphoma

Hemato_Mar's tweet image. cfDNA was detectable in 249 patients (96,9%) and correlated with LDH and Ann Arbor stage. #cellfreeDNA, #ASH2019, #HematologyHospitaldelMar,#lymphoma
Hemato_Mar's tweet image. cfDNA was detectable in 249 patients (96,9%) and correlated with LDH and Ann Arbor stage. #cellfreeDNA, #ASH2019, #HematologyHospitaldelMar,#lymphoma
Hemato_Mar's tweet image. cfDNA was detectable in 249 patients (96,9%) and correlated with LDH and Ann Arbor stage. #cellfreeDNA, #ASH2019, #HematologyHospitaldelMar,#lymphoma
Hemato_Mar's tweet image. cfDNA was detectable in 249 patients (96,9%) and correlated with LDH and Ann Arbor stage. #cellfreeDNA, #ASH2019, #HematologyHospitaldelMar,#lymphoma

ATC 2020 is right around the corner! We'll be presenting new data and hosting an exciting satellite symposium featuring several talks by leading transplant physicians and nephrologists. Read more: natera.com/press-releases… #ATC2020Virtual #cellfreeDNA #Prospera #transplanttwitter

NateraGenetics's tweet image. ATC 2020 is right around the corner! We'll be presenting new data and hosting an exciting satellite symposium featuring several talks by leading transplant physicians and nephrologists. Read more: natera.com/press-releases…

#ATC2020Virtual #cellfreeDNA #Prospera #transplanttwitter

Delighted to present our forthcoming trial, NOMINATE, at today’s industry sponsored symposium #TTS2022. @NateraNeph @RoyalFreeNHS @RenalUCL @UCLDivofSurgery #cellfreeDNA #Transplant

rezamotallebov's tweet image. Delighted to present our forthcoming trial, NOMINATE, at today’s industry sponsored symposium #TTS2022. @NateraNeph @RoyalFreeNHS @RenalUCL @UCLDivofSurgery #cellfreeDNA #Transplant

#BBI member, Dr. Pritchard reflects on #CellFreeDNA working group: “[It] brought together researchers & clinicians from a variety of disease states & made me realize larger applications & appreciate that #cancer is just the tip of the iceberg in potential for this technology.”

BrotmanBaty's tweet image. #BBI member, Dr. Pritchard reflects on #CellFreeDNA working group: “[It] brought together researchers & clinicians from a variety of disease states & made me realize larger applications & appreciate that #cancer is just the tip of the iceberg in potential for this technology.”

Closing in on #cfDNA -based detection and diagnosis rdcu.be/b5JWM #cellfreeDNA - via ⁦@NatureRevCancer

surgeonretina's tweet image. Closing in on #cfDNA -based detection and diagnosis

rdcu.be/b5JWM

#cellfreeDNA

- via ⁦@NatureRevCancer⁩

Be cautious in diagnosis of #cancer from #cellfreeDNA, per #ASCO17 abstract: #clonalhematopoiesis also makes #cfDNA! ow.ly/XUqi30cmTSP

AlexSilverMSTP's tweet image. Be cautious in diagnosis of #cancer from #cellfreeDNA, per #ASCO17 abstract: #clonalhematopoiesis also makes #cfDNA! ow.ly/XUqi30cmTSP

Anyone has experience with extracting cell-free DNA from small volumes of cell media (20-50microlit)? Any recommended kits and protocols ? Usually cfDNA kits handle larger input volumes (0.5-1 ml) #CellBiology #cfDNA #cellFreeDNA #Genomics


New evidence that a large proportion of human blood plasma #cellfreeDNA is localized in #exosomes - bit.ly/2x91Erm - @unmc


Circulating tumor DNA: A new generation of cancer biomarkers is.gd/9zb6P4 #CellFreeDNA


Our GEN II #DNA synthesis provides low-cost gene fragments that require ZERO plasmids, ZERO transformations, ZERO colony picking. Get NGS-verified, high-accuracy #EnfiniaDNA for $0.07/bp w Early Access & save yourself from cloning. Join →hubs.ly/Q03VQvf_0 #CellFreeDNA

ElegenBio's tweet image. Our GEN II #DNA synthesis provides low-cost gene fragments that require ZERO plasmids, ZERO transformations, ZERO colony picking.

Get NGS-verified, high-accuracy #EnfiniaDNA for $0.07/bp w Early Access & save yourself from cloning.

Join →hubs.ly/Q03VQvf_0 

#CellFreeDNA

Touchlight’s #cellfreedna technology offers a powerful alternative to #plasmiddna, with four key advantages: Developing gene therapies, #mRNA vaccines, or cell-based treatments, dbDNA™ provides the speed, purity, and flexibility you need. Learn more: eu1.hubs.ly/H0psqNc0


👀#BehindTheScience Breakthroughs🧬 We’re proud of #TeamElegen—our innovators, scientists & engineers driving the Gen II #CellFreeDNA Platform forward. Their ingenuity is making #DNA faster & more accessible than ever.👏 👉bit.ly/4nMG01W #Innovation #GeneticMedicine

ElegenBio's tweet image. 👀#BehindTheScience Breakthroughs🧬 
We’re proud of #TeamElegen—our innovators, scientists & engineers driving the Gen II #CellFreeDNA Platform forward. Their ingenuity is making #DNA faster & more accessible than ever.👏

👉bit.ly/4nMG01W

#Innovation #GeneticMedicine
ElegenBio's tweet image. 👀#BehindTheScience Breakthroughs🧬 
We’re proud of #TeamElegen—our innovators, scientists & engineers driving the Gen II #CellFreeDNA Platform forward. Their ingenuity is making #DNA faster & more accessible than ever.👏

👉bit.ly/4nMG01W

#Innovation #GeneticMedicine
ElegenBio's tweet image. 👀#BehindTheScience Breakthroughs🧬 
We’re proud of #TeamElegen—our innovators, scientists & engineers driving the Gen II #CellFreeDNA Platform forward. Their ingenuity is making #DNA faster & more accessible than ever.👏

👉bit.ly/4nMG01W

#Innovation #GeneticMedicine

Touchlight’s #cellfreedna technology offers a powerful alternative to #plasmiddna, with four key advantages: Developing gene therapies, #mRNA vaccines, or cell-based treatments, dbDNA™ provides the speed, purity, and flexibility you need. Learn more: eu1.hubs.ly/H0pcSLT0


Excited to share that Lisa Caproni, PhD, from Touchlight will speak at the #PDAIreland Conference on 27 Nov in Dublin! She’ll present on scalable, #cellFreeDNA manufacturing with Touchlight’s dbDNA™ platform. Register here: eu1.hubs.ly/H0nY07Y0


@Biocompare highlights upstream bottlenecks in #GeneTherapy. At @ElegenBio, we see another: #DNA supply. Plasmids slow down progress. #CellFreeDNA delivers speed + fidelity to unlock the next wave of therapies.  🧬Read: bit.ly/41GbazQ #CellTherapy #EnfiniaDNA

ElegenBio's tweet image. @Biocompare highlights upstream bottlenecks in #GeneTherapy. 

At @ElegenBio, we see another: #DNA supply. Plasmids slow down progress. #CellFreeDNA delivers speed + fidelity to unlock the next wave of therapies. 

🧬Read: bit.ly/41GbazQ

#CellTherapy #EnfiniaDNA

"Cell-Free Insights" is Touchlight's insightful newsletter. Get the latest news, trends & innovative solutions in genetic medicine. Stay ahead of the curve here: eu1.hubs.ly/H0mR1xh0 #CellFreeDNA #SyntheticDNA #enzymaticDNA

TouchlightDNA's tweet image. "Cell-Free Insights" is Touchlight's insightful newsletter. Get the latest news, trends & innovative solutions in genetic medicine. Stay ahead of the curve here: eu1.hubs.ly/H0mR1xh0

#CellFreeDNA #SyntheticDNA #enzymaticDNA

Therapeutic Effects of DNase I on Peripheral and Local Markers of Liver Injury and Neutrophil Extracellular Traps in a Model of Alcohol-Related Liver Disease Full text👉buff.ly/RLcjIwz #AlcoholRelatedLiverDisease #NETs #CellFreeDNA #Deoxyribonuclease #LiverHealth

MDPIBiologySubj's tweet image. Therapeutic Effects of DNase I on Peripheral and Local Markers of Liver Injury and Neutrophil Extracellular Traps in a Model of Alcohol-Related Liver Disease 

Full text👉buff.ly/RLcjIwz 

#AlcoholRelatedLiverDisease 
#NETs 
#CellFreeDNA 
#Deoxyribonuclease 
#LiverHealth

#Article in @MedComm_MC Genome-Wide 5-Methylcytosine and 5-Hydroxymethylcytosine Signatures Analysis of Plasma Cell-Free DNA in Schizophrenia 🔗doi.org/10.1002/mco2.7… #schizophrenia #cellfreeDNA #cfDNA #methylcytosine #hydroxymethylcytosine #GWAS

MedComm_MC's tweet image. #Article in @MedComm_MC 

Genome-Wide 5-Methylcytosine and 5-Hydroxymethylcytosine Signatures Analysis of Plasma Cell-Free DNA in Schizophrenia 🔗doi.org/10.1002/mco2.7…

#schizophrenia #cellfreeDNA #cfDNA #methylcytosine  #hydroxymethylcytosine  #GWAS

New study! 🪴 Genome-Wide Methylation Sequencing to Identify DNA Methylation Markers for Early-stage #HepatocellularCarcinoma in Liver and Blood Read here⬇️ jeccr.biomedcentral.com/articles/10.11… #DNAmethylationmarkers #CellfreeDNA

JournalofExper1's tweet image. New study! 🪴

Genome-Wide Methylation Sequencing to Identify DNA Methylation Markers for Early-stage #HepatocellularCarcinoma in Liver and Blood

Read here⬇️
jeccr.biomedcentral.com/articles/10.11…

#DNAmethylationmarkers
#CellfreeDNA

Discover the future of cell-free DNA technology with Omega Bio-tek! Visit us at booth #8 during the International Meeting on Cell-free DNA, May 8-9 in Copenhagen. Don't miss out on cutting-edge innovations and expert insights. See you there! #OmegaBioTek #CellFreeDNA

omegabiotek's tweet image. Discover the future of cell-free DNA technology with Omega Bio-tek! Visit us at booth #8 during the International Meeting on Cell-free DNA, May 8-9 in Copenhagen. Don't miss out on cutting-edge innovations and expert insights. See you there! #OmegaBioTek #CellFreeDNA

🔔For those interested in non-invasive prenatal testing (as oneself🙋🏽) don't miss Dr. Dennis Lo, pioneer in🧬 #CellFreeDNA & #NIPT, lecture at #SRI2025 📍Charlotte, NC🇺🇸 🏆Dr. Denis Lo has been awarded by @SRIWomensHealth with #TheMarchOfDimes prize 📅March 29 🕓8:30am

We’re thrilled to announce Dr. Dennis Lo, as the recipient of the March of Dimes Richard B Johnston, Jr., MD Prize! Known as the "father of noninvasive prenatal testing," his work in fetal DNA revolutionized prenatal care. We are honored to recognize his contributions.

SRIWomensHealth's tweet image. We’re thrilled to announce Dr. Dennis Lo, as the recipient of the March of Dimes Richard B Johnston, Jr., MD Prize!

Known as the "father of noninvasive prenatal testing," his work in fetal DNA revolutionized prenatal care. We are honored to recognize his contributions.


ICYMI: Our webinar with @Natera on Cell-free DNA testing as an alternative to surveillance biopsy in children is now available! Watch the recording for insights into this less invasive option: natera.com/resource-libra… #CellFreeDNA #Natera #PediatricHealth #Webinar

transplantfams's tweet image. ICYMI: Our webinar with @Natera on Cell-free DNA testing as an alternative to surveillance biopsy in children is now available! Watch the recording for insights into this less invasive option: 

natera.com/resource-libra… #CellFreeDNA #Natera #PediatricHealth #Webinar

No results for "#cellfreedna"

👀#BehindTheScience Breakthroughs🧬 We’re proud of #TeamElegen—our innovators, scientists & engineers driving the Gen II #CellFreeDNA Platform forward. Their ingenuity is making #DNA faster & more accessible than ever.👏 👉bit.ly/4nMG01W #Innovation #GeneticMedicine

ElegenBio's tweet image. 👀#BehindTheScience Breakthroughs🧬 
We’re proud of #TeamElegen—our innovators, scientists & engineers driving the Gen II #CellFreeDNA Platform forward. Their ingenuity is making #DNA faster & more accessible than ever.👏

👉bit.ly/4nMG01W

#Innovation #GeneticMedicine
ElegenBio's tweet image. 👀#BehindTheScience Breakthroughs🧬 
We’re proud of #TeamElegen—our innovators, scientists & engineers driving the Gen II #CellFreeDNA Platform forward. Their ingenuity is making #DNA faster & more accessible than ever.👏

👉bit.ly/4nMG01W

#Innovation #GeneticMedicine
ElegenBio's tweet image. 👀#BehindTheScience Breakthroughs🧬 
We’re proud of #TeamElegen—our innovators, scientists & engineers driving the Gen II #CellFreeDNA Platform forward. Their ingenuity is making #DNA faster & more accessible than ever.👏

👉bit.ly/4nMG01W

#Innovation #GeneticMedicine

@beth_psaila kicks off first session of day @OxfordCancer #OxSymp23 on how #megakaryocytes & plts provide window into variants as they gobble up #CellFreeDNA •Liquid biopsy •Importance of nucleosomal footprint •full representation of gDNA @MRC_WIMM @OxfordMedSci

LambAlastair's tweet image. @beth_psaila kicks off first session of day @OxfordCancer #OxSymp23 on how #megakaryocytes & plts provide window into variants as they gobble up #CellFreeDNA
•Liquid biopsy
•Importance of nucleosomal footprint
•full representation of gDNA
@MRC_WIMM @OxfordMedSci
LambAlastair's tweet image. @beth_psaila kicks off first session of day @OxfordCancer #OxSymp23 on how #megakaryocytes & plts provide window into variants as they gobble up #CellFreeDNA
•Liquid biopsy
•Importance of nucleosomal footprint
•full representation of gDNA
@MRC_WIMM @OxfordMedSci
LambAlastair's tweet image. @beth_psaila kicks off first session of day @OxfordCancer #OxSymp23 on how #megakaryocytes & plts provide window into variants as they gobble up #CellFreeDNA
•Liquid biopsy
•Importance of nucleosomal footprint
•full representation of gDNA
@MRC_WIMM @OxfordMedSci
LambAlastair's tweet image. @beth_psaila kicks off first session of day @OxfordCancer #OxSymp23 on how #megakaryocytes & plts provide window into variants as they gobble up #CellFreeDNA
•Liquid biopsy
•Importance of nucleosomal footprint
•full representation of gDNA
@MRC_WIMM @OxfordMedSci

UW Study Demonstrates Tracking of #CellFreeDNA to Origin in Body - go.shr.lc/1NbXrQi @uwgenome

ExosomeRNA's tweet image. UW Study Demonstrates Tracking of #CellFreeDNA to Origin in Body - go.shr.lc/1NbXrQi @uwgenome

Discover the future of cell-free DNA technology with Omega Bio-tek! Visit us at booth #8 during the International Meeting on Cell-free DNA, May 8-9 in Copenhagen. Don't miss out on cutting-edge innovations and expert insights. See you there! #OmegaBioTek #CellFreeDNA

omegabiotek's tweet image. Discover the future of cell-free DNA technology with Omega Bio-tek! Visit us at booth #8 during the International Meeting on Cell-free DNA, May 8-9 in Copenhagen. Don't miss out on cutting-edge innovations and expert insights. See you there! #OmegaBioTek #CellFreeDNA

You’ll find one of our #cellfreeDNA in #cirrhosis & #ALF superstars @Marilen_St presenting a range of work at #EASLcongress 2024, sharing novel circulating signatures in cirrhosis and acute liver failure @EASLnews @EASLedu @DrVishalCPatel @KCH_Research #LiverTwitter #Hepatology

Inst_of_Liver's tweet image. You’ll find one of our #cellfreeDNA in #cirrhosis & #ALF superstars @Marilen_St presenting a range of work at #EASLcongress 2024, sharing novel circulating signatures in cirrhosis and acute liver failure

@EASLnews @EASLedu @DrVishalCPatel @KCH_Research #LiverTwitter #Hepatology

#CellFreeDNA detects Hodgkin/R-S genomic imbalances in early & advanced disease. MRD next? ncbi.nlm.nih.gov/pubmed/26687610

evemariecrane's tweet image. #CellFreeDNA detects Hodgkin/R-S genomic imbalances in early & advanced disease. MRD next? ncbi.nlm.nih.gov/pubmed/26687610
evemariecrane's tweet image. #CellFreeDNA detects Hodgkin/R-S genomic imbalances in early & advanced disease. MRD next? ncbi.nlm.nih.gov/pubmed/26687610

New Open🔓 Access Study on Circulating #CellfreeDNA in health and disease — the relationship to #healthbehaviours, #ageing phenotypes and #metabolomics by Laura Kananen et al. link.springer.com/article/10.100… @karolinskainst @TampereUni @UniKonstanz @uniinnsbruck

GeroScienceAGE's tweet image. New Open🔓 Access Study on Circulating #CellfreeDNA in health and disease — the relationship to #healthbehaviours, #ageing phenotypes and #metabolomics by Laura Kananen et al. 
link.springer.com/article/10.100…
@karolinskainst @TampereUni @UniKonstanz
@uniinnsbruck

The people who make #ICGEBCapeTown Dada Oluwaseyi Temilola #ICGEB Arturo Falaschi PhD Fellow 'My research is focused on the role of #cellfreeDNA in the diagnosis and prognosis of #prostatecancer in the #SouthAfrican population'

ICGEBCapeTown's tweet image. The people who make #ICGEBCapeTown

Dada Oluwaseyi Temilola #ICGEB Arturo Falaschi PhD Fellow

'My research is focused on the role of #cellfreeDNA in the diagnosis and prognosis of #prostatecancer in the #SouthAfrican population'

A new method uses #cellfreeDNA to test urinary tract infections to provide more info about patients’ #bacterial & viral composition, based on a new study in @NatureComms, by @john__r__lee of WCM & @nyphospital and @DeVlaminckLab of @CornellBME bit.ly/2n7yBOL

WeillCornell's tweet image. A new method uses #cellfreeDNA to test urinary tract infections to provide more info about patients’ #bacterial & viral composition, based on a new study in @NatureComms, by @john__r__lee of WCM & @nyphospital and @DeVlaminckLab of @CornellBME bit.ly/2n7yBOL

Liquid Biopsy Surge Is Reaching Beyond Cancer to Infectious Disease @QmedNews #cellfreeDNA #microbes #kariustest ow.ly/Yng730ejGt6

KariusInc's tweet image. Liquid Biopsy Surge Is Reaching Beyond Cancer to Infectious Disease @QmedNews #cellfreeDNA #microbes #kariustest ow.ly/Yng730ejGt6

Diagnosing #transplant #rejection using #cellfreeDNA. John Whitlam: What is the Fourier of cfDNA in predicting rejection #TSANZASM19 #tsanzconf @TSANZ_txsoc

BasuNephro's tweet image. Diagnosing #transplant #rejection using #cellfreeDNA. John Whitlam: 
What is the Fourier of cfDNA in predicting rejection
#TSANZASM19 #tsanzconf @TSANZ_txsoc

On et al. from @Niigata_Univ_O show that diagnostic mutations can be reliably detected from #cellfreeDNA in the cystic fluid of glial tumors, which may be an alternative sampling source to tumor tissue link.springer.com/article/10.100…

JNeurooncol's tweet image. On et al. from @Niigata_Univ_O show that diagnostic mutations can be reliably detected from #cellfreeDNA in the cystic fluid of glial tumors, which may be an alternative sampling source to tumor tissue 
link.springer.com/article/10.100…

#SLAS2018 is coming up fast! If your research is around circulating, cell-free DNA, come talk with us at booth 414 on our high throughput #cfDNA extraction solutions. See how we can currently automate 192 samples in 2 hours. Coming soon, 8 mL. #cellfreeDNA #NIPT

omegabiotek's tweet image. #SLAS2018 is coming up fast! If your research is around circulating, cell-free DNA, come talk with us at booth 414 on our high throughput #cfDNA extraction solutions.  See how we can currently automate 192 samples in 2 hours. Coming soon, 8 mL. #cellfreeDNA #NIPT

Visit our #AGBT2020 posters! Speak with Joe Rotsinger to learn how to generate sequencing libraries from difficult samples such as #FFPE or #cellfreeDNA: ow.ly/J2ib50yeGCu #eXXpressyourself #NGS #thatsgoodscience #takarabio

TakaraBioUSA's tweet image. Visit our #AGBT2020 posters! Speak with Joe Rotsinger to learn how to generate sequencing libraries from difficult samples such as #FFPE or #cellfreeDNA: ow.ly/J2ib50yeGCu
#eXXpressyourself #NGS #thatsgoodscience #takarabio

Great talk by Max Diehl at @AACR #liquidbiopsies about how #cellfreeDNA assays can facilitate new clinical paradigms in part because they can be done repeatedly as opposed to other measurements.

AuclairDan's tweet image. Great talk by Max Diehl at @AACR #liquidbiopsies about how #cellfreeDNA assays can facilitate new clinical paradigms in part because they can be done repeatedly as opposed to other measurements.
AuclairDan's tweet image. Great talk by Max Diehl at @AACR #liquidbiopsies about how #cellfreeDNA assays can facilitate new clinical paradigms in part because they can be done repeatedly as opposed to other measurements.
AuclairDan's tweet image. Great talk by Max Diehl at @AACR #liquidbiopsies about how #cellfreeDNA assays can facilitate new clinical paradigms in part because they can be done repeatedly as opposed to other measurements.
AuclairDan's tweet image. Great talk by Max Diehl at @AACR #liquidbiopsies about how #cellfreeDNA assays can facilitate new clinical paradigms in part because they can be done repeatedly as opposed to other measurements.

@Biocompare highlights upstream bottlenecks in #GeneTherapy. At @ElegenBio, we see another: #DNA supply. Plasmids slow down progress. #CellFreeDNA delivers speed + fidelity to unlock the next wave of therapies.  🧬Read: bit.ly/41GbazQ #CellTherapy #EnfiniaDNA

ElegenBio's tweet image. @Biocompare highlights upstream bottlenecks in #GeneTherapy. 

At @ElegenBio, we see another: #DNA supply. Plasmids slow down progress. #CellFreeDNA delivers speed + fidelity to unlock the next wave of therapies. 

🧬Read: bit.ly/41GbazQ

#CellTherapy #EnfiniaDNA

Delighted to present our forthcoming trial, NOMINATE, at today’s industry sponsored symposium #TTS2022. @NateraNeph @RoyalFreeNHS @RenalUCL @UCLDivofSurgery #cellfreeDNA #Transplant

rezamotallebov's tweet image. Delighted to present our forthcoming trial, NOMINATE, at today’s industry sponsored symposium #TTS2022. @NateraNeph @RoyalFreeNHS @RenalUCL @UCLDivofSurgery #cellfreeDNA #Transplant

Struggling to get meaningful data from #FFPE & #cellfreeDNA? Visit our #AGBT2020 poster 512 to learn about a modular NGS library prep kit for accurate, reproducible sequencing readouts from these sample types: ow.ly/UUrx50ym0zr #NGS #cancerresearch #eXXpressyourself

TakaraBioUSA's tweet image. Struggling to get meaningful data from #FFPE & #cellfreeDNA? Visit our #AGBT2020 poster 512 to learn about a modular NGS library prep kit for accurate, reproducible sequencing readouts from these sample types: ow.ly/UUrx50ym0zr
#NGS #cancerresearch #eXXpressyourself

Loading...

Something went wrong.


Something went wrong.


United States Trends